These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20560933)

  • 21. Design and inference for the intent-to-treat principle using adaptive treatment.
    Dawson R; Lavori PW
    Stat Med; 2015 Apr; 34(9):1441-53. PubMed ID: 25581413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomization, statistics, and causal inference.
    Greenland S
    Epidemiology; 1990 Nov; 1(6):421-9. PubMed ID: 2090279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The compliance score as a regressor in randomized trials.
    Joffe MM; Ten Have TR; Brensinger C
    Biostatistics; 2003 Jul; 4(3):327-40. PubMed ID: 12925501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating the causal effect of compliance on binary outcome in randomized controlled trials.
    Goetghebeur E; Molenberghs G; Katz J
    Stat Med; 1998 Feb; 17(3):341-55. PubMed ID: 9493258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond intent to treat (ITT): A complier average causal effect (CACE) estimation primer.
    Peugh JL; Strotman D; McGrady M; Rausch J; Kashikar-Zuck S
    J Sch Psychol; 2017 Feb; 60():7-24. PubMed ID: 28164801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model selection criterion for causal parameters in structural mean models based on a quasi-likelihood.
    Taguri M; Matsuyama Y; Ohashi Y
    Biometrics; 2014 Sep; 70(3):721-30. PubMed ID: 24621405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating causal effects from a randomized clinical trial when noncompliance is measured with error.
    Boatman JA; Vock DM; Koopmeiners JS; Donny EC
    Biostatistics; 2018 Jan; 19(1):103-118. PubMed ID: 28605411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bounds on causal effects in randomized trials with noncompliance under monotonicity assumptions about covariates.
    Chiba Y
    Stat Med; 2009 Nov; 28(26):3249-59. PubMed ID: 19777494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sharp nonparametric bounds and randomization inference for treatment effects on an ordinal outcome.
    Chiba Y
    Stat Med; 2017 Nov; 36(25):3966-3975. PubMed ID: 28703430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tom Ten Have's contributions to causal inference and biostatistics: review and future research directions.
    Small DS; Joffe MM; Lynch KG; Roy JA; Russell Localio A
    Stat Med; 2014 Sep; 33(20):3421-33. PubMed ID: 23255088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bias analysis of the instrumental variable estimator as an estimator of the average causal effect.
    Chiba Y
    Contemp Clin Trials; 2010 Jan; 31(1):12-7. PubMed ID: 19879376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysis.
    Baker SG; Kramer BS
    Stat Methods Med Res; 2005 Aug; 14(4):349-67. PubMed ID: 16178137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance.
    Chan KC
    Contemp Clin Trials; 2012 Jul; 33(4):786-93. PubMed ID: 22484340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating drug effects in the presence of placebo response: causal inference using growth mixture modeling.
    Muthén B; Brown HC
    Stat Med; 2009 Nov; 28(27):3363-85. PubMed ID: 19731223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A more powerful exact test of noninferiority from binary matched-pairs data.
    Lloyd CJ; Moldovan MV
    Stat Med; 2008 Aug; 27(18):3540-9. PubMed ID: 18314932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of principal scores to estimate the marginal compliers causal effect of an intervention.
    Porcher R; Leyrat C; Baron G; Giraudeau B; Boutron I
    Stat Med; 2016 Feb; 35(5):752-67. PubMed ID: 26381261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Likelihood inference for exchangeable binary data with varying cluster sizes.
    Stefanescu C; Turnbull BW
    Biometrics; 2003 Mar; 59(1):18-24. PubMed ID: 12762437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials.
    O'Malley AJ; Normand SL
    Biometrics; 2005 Jun; 61(2):325-34. PubMed ID: 16011678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A mixture model using likelihood-based and Bayesian approaches for identifying responders and non-responders in longitudinal clinical trials.
    He J; Entsuah R
    Pharm Stat; 2014; 13(5):327-36. PubMed ID: 25182571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct likelihood analysis versus simple forms of imputation for missing data in randomized clinical trials.
    Beunckens C; Molenberghs G; Kenward MG
    Clin Trials; 2005; 2(5):379-86. PubMed ID: 16315646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.